Community/Retail

The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Latest News

X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

May 15th 2025

The approved injection contains dihydroergotamine (DHE), which is the same medication used in hospitals, in a ready-to-use device.

Zepbound (tirzepatide) -- Image credit: Douglas | stock.adobe.com
CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

May 14th 2025

New OTC Option Offers Patients Itch Relief During Summer Activities
New OTC Option Offers Patients Itch Relief During Summer Activities

May 14th 2025

Injection pen for Weight loss medication Zepbound - Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and weight loss. New York, NY, USA - Jan 10 - Image credit: Douglas | stock.adobe.com
Zepbound Shows Superior Weight Loss Compared to Wegovy in SURMOUNT-5 Trial

May 14th 2025

More News